The Chemours Company (NYSE:CC) Files An 8-K Other Events

Item 8.01 Other Events.

Settlement of PFOA Litigation

As previously reported, approximately 3,500 lawsuits have been
filed in various federal and state courts in Ohio and West
Virginia alleging personal injury from exposure to
perfluorooctanoic acid and its salts, including the ammonium salt
(PFOA), in drinking water as a result of the historical
manufacture or use of PFOA at the Washington Works plant outside
Parkersburg, West Virginia.That plant was previously owned and/or
operated by the performance chemicals segment of E. I. du Pont de
Nemours and Company (DuPont) and is now owned and/or operated by
The Chemours Company (Chemours).These personal injury lawsuits
were consolidated in multi-district litigation in the United
States District Court for the Southern District of Ohio (the
MDL).See PFOA in Note 16 to the Interim Consolidated Financial
Statements in Chemours Quarterly Report on Form 10-Q for the
quarter ended September 30, 2016.

On February 11, 2017, DuPont entered into an agreement in
principle with plaintiffs counsel representing the MDL plaintiffs
providing for a global settlement of all cases and claims in the
MDL, including all filed and unfiled personal injury cases and
claims that are part of the plaintiffs counsels claim inventory,
as well as cases that have been tried to a jury verdict (the
Settlement).The total settlement amount is $670.7 million dollars
in cash, half of which will be paid by Chemours and half paid by
DuPont.DuPonts payment would not be subject to indemnification or
reimbursement by Chemours.In exchange for that payment, DuPont
and Chemours will receive a complete release of all claims by the
settling plaintiffs.The Settlement was entered into solely by way
of compromise and settlement and is not in any way an admission
of liability or fault by DuPont or Chemours.

The Settlement is not subject to court approval.The parties have
agreed to draft a master settlement agreement to effect the terms
of the agreement in principle, which agreement would address the
timing and logistics of the settlement payment and conditions
under which the Settlement might not proceed, including a
walk-away right that enables DuPont to terminate the Settlement
if more than a specified number of plaintiffs determine not to
participate.

Chemours has accrued $335.35 million associated with this matter
at December 31, 2016

DuPont and Chemours have also agreed, subject to and following
the completion of the Settlement, to a limited sharing of
potential future PFOA liabilities (i.e., indemnifiable losses, as
defined in the separation agreement between DuPont and Chemours
(the Separation Agreement)) for a period of five years. During
that five-year period, Chemours would annually pay future PFOA
liabilities up to $25 million and, if such amount is exceeded,
DuPont would pay any excess amount up to the next $25 million
(which payment will not be subject to indemnification by
Chemours), with Chemours annually bearing any further excess
liabilities. After the five-year period, this limited sharing
agreement would expire, and Chemours indemnification obligations
under the Separation Agreement would continue unchanged.Chemours
has also agreed that, upon the Settlement becoming effective, it
will not contest its liability to DuPont under the Separation
Agreement for PFOA liabilities on the basis of ostensible
defenses generally applicable to the indemnification provisions
under the Separation Agreement, including defenses relating to
punitive damages, fines or penalties or attorneys fees, and
waives any such defenses with respect to PFOA
liabilities.Chemours has, however, retained defenses as to
whether any particular PFOA claim is within the scope of the
indemnification provisions of the Separation Agreement.

Press Release

On February 13, 2017, Chemours issued a press release announcing
the Settlement and the other matters described in this Current
Report on Form 8-K.A copy of the press release is attached hereto
as Exhibit 99.1 and is incorporated by reference into this Item
8.01.

Cautionary Statement About Forward-Looking Statements

This document contains forward-looking statements, within the
meaning of the federal securities laws, that involve risks and
uncertainties. Forward-looking statements provide current
expectations of future events based on certain assumptions and
include any statement that does not directly relate to any
historical or current fact. The words believe, expect,
anticipate, plan, estimate, target, project and similar
expressions, among others, generally identify forward-looking
statements, which speak only as of the date the statements were
made.

Forward-looking statements are based on certain assumptions and
expectations of future events which may not be accurate or
realized. Forward-looking statements also involve risks and
uncertainties, many of which are beyond Chemours control.
Additionally, there may be other risks and uncertainties that
Chemours is unable to identify at this time or that Chemours does
not currently expect to have a material impact on its
business.Factors that could cause or contribute to these
differences include: whether the Settlement becomes effective;
the outcome of any pending or future litigation related to PFOA;
the performance by DuPont of its obligations under the
Settlement; the terms of any final agreement between Chemours and
DuPont relating to the Settlement; and other facts discussed in
the Forward-Looking Statements and the Risk Factors sections in
Chemours Annual Report on Form 10-K for the year ended December
31, 2015.Chemours assumes no obligation to revise or update any
forward-looking statement for any reason, except as required by
law.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

About The Chemours Company (NYSE:CC)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment manufactures titanium dioxide (TiO2), which is a pigment used to deliver whiteness, opacity, brightness and protection from sunlight in applications, such as architectural and industrial coatings, plastic packaging, polyvinyl chloride (PVC) window profiles, laminate papers, coated paper and coated paperboard used for packaging. Its Fluoroproducts segment provides fluoroproducts, such as refrigerants and industrial fluoropolymer resins. Its Chemical Solutions segment provides industrial and specialty chemicals used in gold production, oil refining, agriculture, industrial polymers and other industries. The Company operates approximately 30 production facilities located in over 10 countries and serves a range of markets in over 130 countries.

The Chemours Company (NYSE:CC) Recent Trading Information

The Chemours Company (NYSE:CC) closed its last trading session up +0.54 at 28.13 with 1,546,924 shares trading hands.